Statement Of Cash Flows [Abstract]

Medistim - Filing #2616656

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
128 138 NOK
74 133 NOK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
7 403 NOK
7 450 NOK
Cash flows from (used in) investing activities
11 486 NOK
10 639 NOK
Cash flows from (used in) financing activities [abstract]
Repayments of borrowings, classified as financing activities
4 500 NOK
3 000 NOK
Payments of lease liabilities, classified as financing activities
7 502 NOK
6 680 NOK
Dividends paid, classified as financing activities
54 640 NOK
50 052 NOK
Other inflows (outflows) of cash, classified as financing activities
7 589 NOK
1 385 NOK
Cash flows from (used in) financing activities
59 053 NOK
58 347 NOK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
57 599 NOK
5 147 NOK
Cash and cash equivalents
124 866 NOK
65 761 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.